| Accord Healthcare AG - Bendamustin Accord liquid 100 mg/4 ml, Konzentrat zur Herstellung einer Infusionslösung |
| 68870 | | 01 | | Bendamustin Accord liquid 100 mg/4 ml | | Konzentrat zur Herstellung einer Infusionslösung | | L01AA09 | | Bendamustine | | 15.12.2022 | | |
|
| Composition |
| bendamustini hydrochloridum 100 mg ut bendamustini hydrochloridum monohydricum, E 321, macrogolum 300, q.s. ad solutionem. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | Active Agent | Dose |
|---|
| Bendamustini Hydrochloridum | 100 mg |
| | | | Inactive agents | Dose |
|---|
| E 321 | | | Macrogol | 300 |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | | | A | | No | | 002 | 5 | | | A | | No |
|
